The lab of Dr. Nicholas Brady at Weill Cornell Medicine is focused on understanding how transcription factors cooperate with epigenetic changes during the development of neuroendocrine prostate cancer (NEPC). Our group is made up of postdoctoral researchers, graduate students performing their M.S. or Ph.D. thesis work, and laboratory research technicians.
Affiliations
We collaborate with many research groups and have access to a number of shared resources at Weill Cornell Medicine.
Job Opportunities
Click to find out about opportunities to join the ongoing research in the Brady Lab at Weill Cornell Medicine.